Sylke, Inc.
SYLKE® Skin Closure is a sterile, single-use, silk fibroin mesh strip with a pressure-sensitive adhesive intended for topical skin closure and wound support. The device is used to hold together well-approximated skin edges of a wound, and to cover and protect the wound. Learn more at sylke.com.
Funding history
About Sylke, Inc.
How much funding has Sylke, Inc. raised?
Sylke, Inc. has raised $20.3M in total funding. The most recent round was Series B.
Where is Sylke, Inc. headquartered?
Sylke, Inc. is headquartered in La Jolla, CA.
What does Sylke, Inc. do?
SYLKE® Skin Closure is a sterile, single-use, silk fibroin mesh strip with a pressure-sensitive adhesive intended for topical skin closure and wound support. The device is used to hold together well-approximated skin edges of a wound, and to cover and protect the wound. Learn more at sylke.com.
What problem does Sylke, Inc. solve?
Traditional wound and incision closure methods like cyanoacrylate glue are slow to set and uncomfortable for patients.
What's Sylke, Inc.'s solution?
SYLKE makes a biocompatible skin closure product woven from silk fibroin that acts as a pressure-sensitive adhesive to hold together skin edges after surgery or minor cuts, used alone or alongside sutures or staples.
What makes Sylke, Inc. different?
It is made from natural silk fibroin rather than a synthetic polymer or cyanoacrylate, contains no latex, is water-resistant, can be worn up to two weeks, and is sourced through a Cradle to Cradle-certified process from mulberry groves in India.
What makes Sylke, Inc. notable?
Sylke's silk-fibroin surgical skin closure product was developed by its founder, Dr. M. Mark Mofid, a practicing reconstructive and plastic surgeon; the company has raised $15.5M, including backing from Vaark Ventures.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.